LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-6.40 Cr | ₹-5.18 Cr | ₹-4.50 Cr | ₹-2.56 Cr | ₹-5.75 Cr |
What is the latest Cash Flow from Financing Activities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-6.40 Cr |
| Mar2024 | ₹-5.18 Cr |
| Mar2023 | ₹-4.50 Cr |
| Mar2022 | ₹-2.56 Cr |
| Mar2021 | ₹-5.75 Cr |
How is Cash Flow from Financing Activities of LINCOLN PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-6.40 Cr | Negative | |
| Mar2024 | ₹-5.18 Cr | Negative | |
| Mar2023 | ₹-4.50 Cr | Negative | |
| Mar2022 | ₹-2.56 Cr | Negative | |
| Mar2021 | ₹-5.75 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,152.2 Cr | 0.4% | -6.4% | -4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 0.4% |
-6.4% |
-4.7% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses